Le Lézard
Classified in: Health
Subjects: PDT, FDA

Sinusleevetm Balloon Device Completes FDA Listing, Dalent Medical Begins Sales In South Florida

MIAMI, Aug. 6, 2019 /PRNewswire/ -- Dalent Medical, a Miami-based company developing innovative devices for Ear, Nose & Throat Doctors is pleased to announce that the Sinusleevetm Balloon Sinus Dilation Sleeve has completed the United States Food and Drug Administration's listing process. The company will begin selling the Sinusleevetm balloon device in their home state of Florida to Otolaryngologists immediately.

Dalent Medical is a Miami-based company that specializes in the development of devices for Ear, Nose & Throat doctors (Otolaryngologists). Founded in 2017, the company's first patented product will be available in 2019. (PRNewsfoto/Dalent Medical)

The Sinusleevetm Balloon is a single-use, disposable, balloon sinus dilation device (BSD) used for treating chronic sinusitis. Developed and manufactured in the United States, this patented device fits over rigid, flexible and reusable positioning and suction devices by way of a conforming sleeve. The Sinusleevetm Balloon accommodates instrumentation of varying sizes and curves, allowing access, simultaneous suction and balloon dilation all in one.

"The Sinusleevetm Balloon was developed by ENTs for ENTs. Previously, we needed more devices on-hand to execute sinus dilation procedures. Now with a more versatile sleeve,  surgeons can streamline costs without limiting their instrument options," said CMO Dr. Agustin Arrieta.

Over 12 million people visit their doctor for symptoms related to Chronic Sinusitis each year and surgeries are on the rise. According to Dr. Arrieta, "Patients are asking for balloon dilation procedures because they can go in for a procedure one afternoon and go to work the next day relieved of sinus symptoms that have nagged them for years. Less invasive devices like the ones we're developing are driving the steady growth of surgeries in this category."

Dalent Medical is in the process of onboarding key hires to start building and managing sales relationships starting in Florida. "Our team has spent years testing and improving this device with help from our ENT advisors and investors. I'm confident we developed a great device and we're excited to get it into doctor's hands. Now that the device is FDA listed, we will shift our focus to marketing and sales," stated CEO, Shawn McCoy.

The Sinusleevetm Balloon is expected to be available across the nation in 2020.


Dalent Medical was launched by a diverse group of founders, investors, and innovators committed to creating solutions for physicians and their patients with sinus related conditions. The Dalent Medical team recognize the need and opportunity to present new, innovative, versatile, lower cost alternatives to help treat those suffering from Chronic Sinusitis.



1-888-4DALENT (1-888-432-5368)

SOURCE Dalent Medical

These press releases may also interest you

at 03:00
On one end of the humility spectrum, there's the braggers. It doesn't matter if all they've done is fry an egg without burning it - the entire world must know of their accomplishments. Next, there's the humble-braggers. They think they're being...

at 02:40
Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced today that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an...

6 déc 2019
BrainCo's prosthetic hand won Time Magazine's Top 100 Inventions of the Year. The prosthetic hand represents an advancement in assistive technology, providing amputees with an intuitively controlled prosthetic at a lower cost. ...

6 déc 2019
Helix BioPharma Corp. ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the voting results of the Company's annual and special meeting of...

6 déc 2019
In the news release, Delta Dental Invests in Startup to Support Healthy Lifestyles Through Partnership with LEAP's PROPTO InsurTech program, issued 06-Dec-2019 by Delta Dental of Michigan over PR Newswire, we are advised by the company that the...

6 déc 2019
Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that they have executed agreements with five investors, including an...

News published on 6 august 2019 at 10:19 and distributed by: